Outlook Super Sunday 2026
Date: 24/05/2026 (AEST)
Venue: HOTA Home of the Arts - Lakeside Room, 135 Bundall Road, Surfers Paradise, QLD, 4217
Provider: Outlook Eye Specialists
Contact: Lovella Stanford, [E] events@outlookeye.com.au, [P] 0755578888
Activity Outline
The doctors at Outlook Eye Specialists are excited to host our annual Super Sunday Optometry Conference. Featuring great speakers, practical talks and practice enhancing dialogue. The meeting aims to provide maximal CPD points and is heavily subsidised to provide excellent value! Network with colleagues and faculty and take your knowledge and practice to the next level. Benefit from clinical pearls, tips and tricks shared by our expert speakers. The talks and experience are geared to allow knowledge use immediately.
Learning Objectives
- Discuss why geographic atrophy is a growing clinical concern and how new treatments aim to slow its progression
- Recognise the key features of complement inhibitor therapy and what patients can realistically expect
- Be aware of emerging treatments on the horizon and how to discuss them with patients
- Know when and how to refer patients with GA for specialist assessment or low vision support
- Describe the proposed link between GLP-1 receptor agonists and ocular complications and explain the current evidence for and against causation.
- Identify diabetic retinopathy patients who require more frequent monitoring when starting GLP-1 therapy.
- Outline an appropriate management pathway for diabetic macular oedema with good presenting vision.
- Discuss the indications and contraindications for prophylactic laser retinopexy in patients with lattice degeneration and retinal holes.
- Describe epidemiology, genetics and risks
- Understand pathophysiology for each condition
- Recognize characteristic clinical features on examination
- Understand risk profile for progressive disease
• explore current management - medical, laser and surgically
- Describe GLP-1 receptor agonists
• understand pharmacodynamic effect and clinical use
- Recognize systemic effects
- Recognize ocular effects and in review evidence for glaucoma protection
- Discuss the evolution of retinal detachment surgery and the clinical presentation of retinal detachment, differential diagnoses of retinal detachment and discuss the indications for different types of retinal detachment repair
- Determine when pterygium have the potential to threaten vision and describe medical therapy for control of pterygium symptoms
- Discuss the characteristics of ocular surface squamous neoplasia
- Differentiate conjunctival pigmented lesions
- Manage bacterial keratitis and discuss the role of corneal scraping
- Differentiate normal aging from glaucoma progression
· Be aware of the causes of chronic conjunctivitis
- Revise lid anatomy and the aetiologic factors in entropion development
- Discuss the treatment of entropion - both medical and surgical and the prevention of recurrent entropion
- Revise anatomy of ocular blood supply
- Outline common causes for arterial and capillary occlusions and ocular ischaemia
- Correlate symptoms with signs
and how to triage, investigate and ocular ischaemia
Max CPD hours awarded: 7.25
Session Information
| Name |
|---|
| Eyelid Malposition |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Pigmentary and Pseudoexfoliative Glaucoma |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| The Ischemic Retina - Dr Paul Ng Memorial Lecture |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| GLP1 Receptor Agonists – A Miracle Drug and It’s Glaucoma Miracle? |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| From Buckles to Bubbles – The Evolution of Retinal Detachment Repair |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Anterior Segment – What to do when… |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Retinal Controversies 2025 |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Ocular Surface Tumours and Pterygium |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Beyond Monitoring: Managing Geographic Atrophy in Modern Practice |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Interactive Quiz |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
|---|
| Eyelid Malposition | Yes | Yes | Yes | 0.5 | 0.75 |
| Pigmentary and Pseudoexfoliative Glaucoma | Yes | Yes | Yes | 0.5 | 0.75 |
| The Ischemic Retina - Dr Paul Ng Memorial Lecture | Yes | Yes | Yes | 0.5 | 0.75 |
| GLP1 Receptor Agonists – A Miracle Drug and It’s Glaucoma Miracle? | Yes | Yes | Yes | 0.5 | 0.75 |
| From Buckles to Bubbles – The Evolution of Retinal Detachment Repair | Yes | Yes | Yes | 0.5 | 0.75 |
| Anterior Segment – What to do when… | Yes | Yes | No | 0.5 | 0.75 |
| Retinal Controversies 2025 | Yes | Yes | Yes | 0.5 | 0.75 |
| Ocular Surface Tumours and Pterygium | Yes | Yes | Yes | 0.5 | 0.75 |
| Beyond Monitoring: Managing Geographic Atrophy in Modern Practice | Yes | Yes | Yes | 0.5 | 0.75 |
| Interactive Quiz | Yes | Yes | Yes | 0.5 | 0.5 |